Comparison of the restricted mean survival time with the hazard ratio in superiority trials with a time-to-event end point
Author:
Affiliation:
1. Pfizer Inc; Groton CT USA
2. Department of Applied Math and Statistics; Stony Brook University; Stony Brook NY USA
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology,Statistics and Probability
Reference10 articles.
1. Restricted mean life with covariates: modification and extension of a useful survival analysis method;Zucker;J Am Stat Assoc,1998
2. The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt;Royston;Stat Med,2011
3. Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome;Royston;BMC Med Res Method,2013
4. Moving beyond the hazard ratio in quantifying the between-group difference in survival analysis;Uno;J Clin Oncol,2014
5. Alternatives to hazard ratios for comparing the efficacy or safety of therapies in noninferiority studiesalternatives to hazard ratios;Uno;Ann Internal Med,2015
Cited by 60 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Development of new methods for attaching pop-up satellite archival tags to blue sharks (Prionace glauca);Journal of Experimental Marine Biology and Ecology;2024-10
2. High‐dimensional feature screening for nonlinear associations with survival outcome using restricted mean survival time;Stat;2024-04-07
3. Comparison of baseline covariate adjustment methods for restricted mean survival time;Contemporary Clinical Trials;2024-03
4. Sample size calculation for mixture model based on geometric average hazard ratio and its applications to nonproportional hazard;Pharmaceutical Statistics;2023-12-28
5. A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial;Trials;2023-12-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3